Gilead Sciences Inc (GILD)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$103.20

Buy

$105.00

arrow-down$-0.34 (-0.32%)

Prices updated at 18 Apr 2025, 00:43 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Most recent dividend payment

0.790
Cash Dividend
14 Mar 2025
11 Feb 2025
14 Mar 2025
28 Mar 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)202120222023202420250246

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20250.7900-
20243.08000.03
20233.00000.03
20222.92000.03
20212.84000.04
20202.72000.08
20192.52000.11
20182.28000.10
20172.08000.13
20161.84000.43

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20252.770.52
20243.330.59
20233.701.25
20223.400.47
20213.910.36
20204.671.93
20193.882.89
20183.652.19
20172.901.75
20162.5713.60

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202501234

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)2021202220232024202501k2k3k4k

Dividend per share data table

YearDividend per share
20250.7900
20243.0800
20233.0000
20222.9200
20212.8400
20202.7200
20192.5200
20182.2800
20172.0800
20161.8400

% of earnings paid to shareholders data table

YearPayout ratio (%)
2025810.53
20243,400.00
202363.81
2022109.85
202147.87
2020272.45
2019116.04
2018182.79
201723.09
201616.71
Latest Financial Report as of 17 Apr 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.